ROLE OF HEMOTRANSFUSION IN DEVELOPMENT AND COURSE OF RETINOPATHY OF PREMATURITY

Irina Borisovna Astasheva; I G Kan; I I Aksenova; N Yu Ezhova; E V Bezenina; Yu D Kuznetsova; E Yu Pavlyuk; I B Astasheva; I G Kan; I I Aksenova; N Yu Ezhova; E V Bezenina; Yu D Kuznetsova; E Yu Pavlyuk

doi:10.17816/rpoj37416

Russian Pediatric Ophthalmology ›› 2010, Vol. 5 ›› Issue (3) : 13 -15. DOI: 10.17816/rpoj37416

Articles

other

ROLE OF HEMOTRANSFUSION IN DEVELOPMENT AND COURSE OF RETINOPATHY OF PREMATURITY

Author information +

History +

PDF

Abstract

The authors detected a distinct dependence between the number of hemotransfusions during the first 24 hours of life and the severity of retinopathy of prematurity course (RP): infants with "plus"-disease in the early neonatal period underwent transfusions of erythrocytic mass twice as often as in infants with minimal vascular activity; infants with posterior aggressive RP form underwent the procedure four times more often. The RP course with minimal vascular activity after hemotransfusion remains unchanged. After hemotransfusion in infants with severe RP forms ("plus"-disease, posterior aggressive RP) the caliber and tortuousity of the retinal vessels increase, retinal edema accumulates, exudative and hemorrhagic changes swell as well as extraretinal proliferation. It is necessary to avoid hemotransfusions in such infants at the peak of the disease activity.

Keywords

retinopathy of prematurity / "plus"-disease / posterior aggressive retinopathy of prematurity / hemotransfusions

Cite this article

Download citation ▾

Irina Borisovna Astasheva, I G Kan, I I Aksenova, N Yu Ezhova, E V Bezenina, Yu D Kuznetsova, E Yu Pavlyuk, I B Astasheva, I G Kan, I I Aksenova, N Yu Ezhova, E V Bezenina, Yu D Kuznetsova, E Yu Pavlyuk. ROLE OF HEMOTRANSFUSION IN DEVELOPMENT AND COURSE OF RETINOPATHY OF PREMATURITY. Russian Pediatric Ophthalmology, 2010, 5(3): 13-15 DOI:10.17816/rpoj37416

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Анисимова А. В., Тычинкина Н. И., Асташева И. Б. и др. Факторы, влияющие на развитие различных форм ретинопатии недоношенных // Рос. педиатр. офтальмол. - 2007. - № 4. - С. 5-7.

[2]	Сайдашева Э. И. Ретинопатия недоношенных: итоги пятилетнего опыта работы в условиях городского неонатального центра // Рос. педиатр. офтальмол. - 2009. - № 4. - С. 4-7.

[3]	Сидоренко Е. И., Асташева И. Б., Аксенова И. И. и др. Анализ частоты ретинопатии недоношенных в перинатальных центрах г. Москвы // Рос. педиатр. офтальмол. - 2009. - № 4. - С. 8-11.

[4]	Степанова Е. А., Блохина С. И., Коротких С. А., Кулакова М. В. Динамика показателей заболеваемости ретинопатией недоношенных и эффективность лазерного лечения в Свердловской области // Рос. педиатр. офтальмол. - 2010. - № 1. - С. 4-6.

[5]	Aher S., Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants // Cochrane Database Syst. Rev. - 2006. - Vol. 19, N 3. - CD004868.

[6]	Akkoyun I., Oto S., Yilmaz G. et al. Risk factors in the development of mild and severe retinopathy of prematurity // J. AAPOS. - 2006. - Vol. 10, N 5. - P. 449-453.

[7]	Astasheva I., Sidorenko E., Kuznetsova Yu. et al. Factors affecting the course and outcome of serious forms of retinopathy of prematurity // Abstract Book of 35-th Annual Meeting of European Paediatric Ophthalmological Society. - Paris, 2009. - P. 69.

[8]	Beby F., Burillon C., Putet G., Denis P. Retinopathy of prematurity. Results of fundus examination performed in 94 preterm infants // J. Fr. Ophtalmol. - 2004. - Vol. 27, N 4. - P. 337-344.

[9]	Dani C., Reali M. F., Bertini G. et al. The role of blood transfusions and iron intake on retinopathy of prematurity // Early Hum. Dev. - 2001. - Vol. 62, N 1. - P. 57-63.

[10]	Englert J. A., Saunders R. A., Purohit D. et al. The effect of anemia on retinopathy of prematurity in extremely low birth weight infants // J. Perinatol. - 2001. - Vol. 21, N 1. - P. 21-26.

[11]	Fortes Filho J. B., Eckert G. U., Valiatti F. B. et al. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP) // Graefes Arch. Clin. Exp. Ophthalmol. - 2009. - Dec. 17.

[12]	Gleissner M. W., Spantzel T., Bücker-Nott H. J., Jorch G. Risk factors of retinopathy of prematurity in infants 32 to 36 weeks gestational age // Z. Geburtsh. Neonatol. - 2003. - Bd 207, N 1. - S. 24-28.

[13]	Ikeda H., Kuriyama S. Risk factors for retinopathy of prematurity requiring photocoagulation // Jpn J. Ophthalmol. - 2004. - Vol. 48, N 1. - P. 68-71.

[14]	Pinheiro A. M., da Silva W. A., Bessa C. G. et al. Incidence and risk factors of retinopathy of prematurity in University Hospital Onofre Lopes, Natal (RN)-Brazil // Arq. Bras. Oftalmol. - 2009. - Vol. 72, N 4. - P. 451-456.

[15]	Schneider J. K., Gardner D. K., Cordero L. Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants // Pharmacotherapy. - 2008. - Vol. 28, N 11. - P. 1335-1340.

[16]	Volante E., Braibanti S., Musetti M. et al. Retinopathy of prematurity: incidence and risk factors // Acta Biomed. Ateneo Parmense. - 2000. - Vol. 71. - Suppl. 1. - P. 615-620.